sequencing-based diagnostics Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection. NantHealth Q1 Revenues Decline 11 Percent NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions. Rare Disease Screening Firm 3billion Closes $13M Series C Financing The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay The hybridization-based test may provide better detection of emerging COVID-19 variants of concern, due to a higher tolerance for probe mismatches than in PCR. Mar 16, 2021 Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China Feb 25, 2021 NantHealth Q4 Revenues Flat From Year Ago Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 16, 2021 Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection Feb 8, 2021 Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 21, 2021 Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test Premium Jan 14, 2021 Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 7, 2021 Clear Labs, Integrated DNA Technologies Expand Partnership to Include COVID-19 Testing Jan 5, 2021 Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance Dec 16, 2020 Illumina, Emedgene Partner on Automated Genomic Data Interpretation Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing Dec 2, 2020 China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis Nov 24, 2020 Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform Premium Nov 18, 2020 Lurie Children's Hospital Details Migration of Clinical Diagnostics Lab to hg38 Reference Genome Premium Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Nov 11, 2020 Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.